Smart Patch Could Detect Fentanyl and Deliver Automatic Overdose Aid

Current reversal depends on timely administration of naloxone, which is not always available or feasible during solitary use. Accidental overdoses can also occur during legitimate pain management when dosing becomes confused. To help address this challenge, researchers have developed a wearable microneedle patch that detects fentanyl in the body and automatically releases naloxone.

The iNal patch was developed by a team in Virginia Tech’s Department of Biological Systems Engineering, which spans the College of Agriculture and Life Sciences and the College of Engineering. The work, published in Advanced Science, proposes autonomous, closed‑loop opioid reversal for harm reduction. The goal is to enable rescue without relying on a bystander.

The patch integrates an array of 121 microneedles designed to penetrate only to the interstitial fluid beneath the skin while minimizing tissue injury. Within the patch, porous silica nanoparticles are loaded with naloxone, an opioid receptor antagonist. Fentanyl‑sensitive molecular gates cap the nanoparticle pores. When fentanyl contacts the sensor, the gates open to release naloxone in proportion to the detected concentration. Because only a fraction of pores open with each event, the system retains a reserve for repeated responses.

In laboratory tests, fentanyl exposure triggered naloxone release within minutes. The amount released increased as fentanyl concentrations rose, and the system maintained responsive delivery for up to 24 hours. These findings supported progression to in vivo evaluation.

In mouse studies, the patch released more naloxone as fentanyl doses increased and remained responsive through at least three separate fentanyl exposures. Animals treated with the patch displayed substantially fewer opioid‑induced symptoms than untreated controls. The team observed no significant signs of irritation or other adverse effects attributable to the patch. Further research is needed to assess durability over time, performance across skin types and real‑world conditions, and responsiveness to different opioids.

The project began in 2022 and included contributors from biological systems engineering, the Virginia Tech College of Science, the School of Neuroscience, the University of Wisconsin-Madison, the University of California Riverside, and the University of Sydney. A patent application has been filed, and efforts are underway to advance the technology toward product development. The underlying chemistry could be adapted to recognize other opioids or deliver alternative antagonists.

“In general situations when there’s an overdose, we need to have someone there to save you. In this case, we don’t need a bystander because we’re protected all the time,” said Wujin Sun, assistant professor of biological systems engineering at Virginia Tech.

“The most exciting moment came from the animal studies. Seeing the patch respond to fentanyl exposure and effectively reverse opioid-induced effects showed us that the technology could potentially work beyond the laboratory,” said Penghui Zhao, visiting instructor in Virginia Tech’s Academy of Integrated Science.

Related Links
Virginia Tech College of Science